Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Taussky

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Journal of Contemporary Brachytherapy|September 28, 2017
Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?Daniel Taussky, Levon Igidbashian, David Donath, et al.
BMC Cancer|August 22, 2015
Neutrophil count is associated with survival in localized prostate cancerHouda Bahig, Daniel Taussky, Guila Delouya, et al.
Journal of Contemporary Brachytherapy|June 4, 2016
Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical resultsOlivier Lauche, Guila Delouya, Daniel Taussky, et al.
Cureus|June 1, 2018
Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance ImagingGuila Delouya, Jean-Francois Carrier, Renée Xavier-Larouche, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancerDavid A Tiberi, Jean-François Carrier, Marie-Claude Beauchemin, et al.
Cancer|August 26, 2010
Influence of abdominal adiposity, waist circumference, and body mass index on clinical and pathologic findings in patients treated with radiotherapy for localized prostate cancerThomas Zilli, Miguel Chagnon, Thu Van Nguyen, et al.
Cancer Epidemiology|November 19, 2011
The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancerGuila Delouya, Gabriel Kaufman, Marie-Pierre Sylvestre, et al.
Cancers|October 14, 2022
Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 DichlorideKevin Kaulanjan, Johanna Dahan, Cédric Charrois-Durand, et al.
Brachytherapy|July 30, 2013
Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factorsCiprian Chira, Daniel Taussky, Nelson Gruszczynski, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2003
Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicityRaymond Miralbell, Daniel Taussky, Olivier Rinaldi, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Journal of Contemporary Brachytherapy|September 28, 2017
Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?Daniel Taussky, Levon Igidbashian, David Donath, et al.
BMC Cancer|August 22, 2015
Neutrophil count is associated with survival in localized prostate cancerHouda Bahig, Daniel Taussky, Guila Delouya, et al.
Journal of Contemporary Brachytherapy|June 4, 2016
Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical resultsOlivier Lauche, Guila Delouya, Daniel Taussky, et al.
Cureus|June 1, 2018
Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance ImagingGuila Delouya, Jean-Francois Carrier, Renée Xavier-Larouche, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancerDavid A Tiberi, Jean-François Carrier, Marie-Claude Beauchemin, et al.
Cancer|August 26, 2010
Influence of abdominal adiposity, waist circumference, and body mass index on clinical and pathologic findings in patients treated with radiotherapy for localized prostate cancerThomas Zilli, Miguel Chagnon, Thu Van Nguyen, et al.
Cancer Epidemiology|November 19, 2011
The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancerGuila Delouya, Gabriel Kaufman, Marie-Pierre Sylvestre, et al.
Cancers|October 14, 2022
Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 DichlorideKevin Kaulanjan, Johanna Dahan, Cédric Charrois-Durand, et al.
Brachytherapy|July 30, 2013
Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factorsCiprian Chira, Daniel Taussky, Nelson Gruszczynski, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2003
Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicityRaymond Miralbell, Daniel Taussky, Olivier Rinaldi, et al.
Pageof 12